Skip to main content
ACON
NASDAQ Life Sciences

Aclarion的Nociscan技术在伦敦诊所接近100次扫描，表明其采用率不断增长

feedReported by GlobeNewswire
Sentiment info
Positive
Importance info
7
Price
$3.53
Mkt Cap
$7.783M
52W Low
$2.34
52W High
$12.99
Market data snapshot near publication time

summarizeSummary

Aclarion宣布其Nociscan技术在The London Clinic的采用率不断增长，截至目前已完成近100次扫描。该公司发布了一段新视频，视频中一位顾问脊髓神经外科医生强调了该产品在评估慢性下背痛方面的使用。对于一家微型医疗技术公司来说，在一家领先的国际中心持续的医生参与和将其整合到临床实践中是一个积极的，尽管有些微妙的，其核心产品商业推动力的指标。这个消息为公司的商业进展提供了更新，这对于其估值至关重要。投资者将关注继续采用率和扩展到其他诊所的进展。

在该公告发布时，ACON的交易价格为$3.53，交易所为NASDAQ，所属行业为Life Sciences，市值约为$778.3万。 52周交易区间为$2.34至$12.99。 这则新闻被评估为积极市场情绪，重要性评分为7/10。 来源：GlobeNewswire。

show_chartPrice Chart

Share this article

Copied!

feed ACON - Latest Insights

ACON
Apr 27, 2026, 4:05 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Aclarion Seeks Shareholder Approval for Significant Equity Plan Expansion, Authorizing 18.56% Potential Dilution
Sentiment: Negative
View Wiseek Article
ACON
Apr 22, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Aclarion Authorizes $2.5M Share Repurchase Program, Signaling Confidence
Sentiment: Positive
View Wiseek Article
ACON
Apr 16, 2026, 6:47 AM EDT
Source: GlobeNewswire
Importance Score:
8
Aclarion Secures Key U.S. Patent for AI-Driven Chronic Back Pain Assessment Platform
Sentiment: Positive
View Wiseek Article
ACON
Apr 14, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Aclarion's Nociscan AI Technology Wins Pinnacle Award for Innovation
Sentiment: Positive
View Wiseek Article
ACON
Apr 07, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Aclarion's Nociscan Nears 100 Scans at London Clinic, Signaling Growing Adoption
Sentiment: Positive
View Wiseek Article
ACON
Apr 03, 2026, 5:02 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Aclarion Seeks Shareholder Approval for Major Equity Plan Expansion and Re-election of Contested Director
Sentiment: Negative
View Wiseek Article
ACON
Mar 24, 2026, 8:00 AM EDT
Source: Access Newswire
Importance Score:
8
Activist Investor Demands Board Member Resignation at Aclarion Amid 99% Stock Decline
Sentiment: Negative
View Wiseek Article
ACON
Mar 19, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Aclarion Adopts 'Poison Pill' Stockholder Rights Plan to Deter Hostile Takeovers
Sentiment: Negative
View Wiseek Article
ACON
Jan 13, 2026, 9:00 AM EST
Filing Type: 8-K
Importance Score:
9
Aclarion Secures $10.4M Financing at Premium, Extends Cash Runway into 2028
Sentiment: Positive
View Wiseek Article
ACON
Jan 09, 2026, 9:03 AM EST
Filing Type: 8-K
Importance Score:
9
Aclarion to Raise $10.36M in Highly Dilutive Offering at Deep Discount
Sentiment: Negative
View Wiseek Article